Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

New approaches in the management of multiple sclerosis.
Pharmacology and therapeutic potential of interferons.
TECFIDERA® Data Confirm Strong and Sustained Efficacy in Newly Diagnosed MS Patients and Real-World Effectiveness
Fatal Acute Myeloid Leukemia With 11q23 MLL Gene Rearrangement Following Mitoxantrone Treatment in a Case of Childhood-onset Multiple Sclerosis.
Fourth PML Case With Tecfidera in MS Calls for Vigilance
Santhera to discontinue sale of Catena® in Canada
US court permits generic version of Teva MS drug a year sooner
FDA approval letter for daclizumab for the prophylaxis of acute organ rejection in patients receiving renal transplants
Teva and Active Biotech remain committed to the development of NERVENTRA® (laquinimod) for multiple sclerosis following the negative opinion from the EMA's CHMP
Oxidative modification of serum proteins in multiple sclerosis.
The OPTimization of interferon for MS study: 375 microg interferon beta-1b in suboptimal responders.
Vitamin D and multiple sclerosis: epidemiology, immunology, and genetics.
Imovane: Best Online Pharmacy
Rituximab, an anti-CD20 monoclonal antibody: History & mechanism: Off label rituximab use in transplant patients
Pregnancy outcomes in patients exposed to interferon beta-1b.
Federation of Clinical Immunology Societies 2012
Synthetic Biologics Reports Results of Independent Third Party Evaluations of Trimesta™ Data from Investigator-Sponsored Phase 2 Clinical Trial for Relapsing-Remitting Multiple Sclerosis
Reviewing the Unmet Needs of Patients with Multiple Sclerosis.
Long extensive transverse myelitis associated with aquaporin-4 antibody and breast cancer: Favorable response to cancer treatment.
Natalizumab treatment during pregnancy - effects on the neonatal immune system.
IgE-Mediated Allergic Reactions after the First Administration of Glatiramer Acetate in Patients with Multiple Sclerosis.
Genzyme’s Lemtrada Approved by the FDA
The effect of low-dose naltrexone on quality of life of patients with multiple sclerosis: a randomized placebo-controlled trial.
Heterogeneity of serum gelatinases MMP-2 and MMP-9 isoforms and charge variants.
UCSF Neuroimmunology Seminar

Pages